Patents-Review.com
🔗 Permalink
Assignee profile:

BIONOR IMMUNO AS

City:

Skien

Country:

Norway

Published Applications:

15

Last publication date:

2018-05-24

Patent Grants:

12

Last grant date:

2019-10-22

Top Inventors for applications by BIONOR IMMUNO AS

These are the the leading inventors for applications assigned to BIONOR IMMUNO AS:

Recent patent applications by BIONOR IMMUNO AS

BIONOR IMMUNO AS based in Skien, NO has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2018-05-24
US20180140694A1
Human necessities

DOSAGE REGIMEN FOR HIV VACCINE

 #2 | 2017-06-15
US20170165321A1
Human necessities

METHOD FOR REDUCING AND/OR DELAYING PATHOLOGICAL EFFECTS OF HUMAN IMMUNODEFICIENCY VIRUS I (HIV) OR FOR REDUCING THE RISK OF DEVELOPING ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)

 #3 | 2017-04-27
US20170112917A1
Human necessities

PEPTIDE SCAFFOLD DESIGN

 #4 | 2017-02-16 ✅ Patent 10,449,245 granted on 2019-10-22
US20170043009A1
Human necessities

Method for reducing HIV-1 reservoir size using multivalent immunogen and reservoir purging agent

 #5 | 2017-01-05 ✅ Patent 10,143,737 granted on 2018-12-04
US20170000876A1
Human necessities

Method for the vaccination against HIV

 #6 | 2016-12-29 ✅ Patent 10,124,059 granted on 2018-11-13
US20160375129A1
Human necessities

Dimeric scaffold peptides comprising HIV-1 GP120 and GP41 epitopes

 #7 | 2016-05-26 ✅ Patent 10,251,949 granted on 2019-04-09
US20160144019A1
Human necessities

Stabilized HIV-1 peptide constructs comprising the gp120 C5 domain and gp41 hydrophilic domain

 #8 | 2015-06-04 ✅ Patent 10,501,499 granted on 2019-12-10
US20150152140A1
Chemistry; metallurgy

Peptides derived from viral proteins for use as immunogens and dosage reactants

 #9 | 2015-05-14 ✅ Patent 10,335,482 granted on 2019-07-02
US20150132255A1
Human necessities

Method of inducing an anti-HIV-1 immune response comprising administering a C5/TM-GP41 peptide dimer

 #10 | 2014-02-13 ✅ Patent 9,493,514 granted on 2016-11-15
US20140044746A1
Chemistry; metallurgy

Dimeric scaffold proteins comprising HIV-1 GP120 and GP41 epitopes

 #11 | 2013-12-19 ✅ Patent 9,550,811 granted on 2017-01-24
US20130337002A1
Chemistry; metallurgy

Peptide scaffold design

 #12 | 2012-10-18 ✅ Patent 9,200,065 granted on 2015-12-01
US20120263720A1
Human necessities

Peptide constructs derived from the GP120 C5 domain and GP41 transmembrane domain

 #13 | 2008-05-08 ✅ Patent 7,709,004 granted on 2010-05-04
US20080107670A1
Chemistry; metallurgy

Method of producing an HIV-1 immune response

 #14 | 2008-05-08 ✅ Patent 7,709,003 granted on 2010-05-04
US20080107669A1
Chemistry; metallurgy

Method of producing an HIV-1 immune response

 #15 | 2005-03-10 ✅ Patent 7,097,971 granted on 2006-08-29
US20050053616A1
Chemistry; metallurgy

HIV-1 peptide, antigen, immunogenic composition, diagnostic method and immunoassay kit

Also check out BIONOR IMMUNO AS's (Skien, Norway) applicant profile with 6 patent applications submitted.

AssigneeID:

49142 ⎘